I’m Conway Gittens reporting from the New York Stock Exchange. Here’s what we’re watching on TheStreet today. Wall Street ...
It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications.
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
The Pittsburgh Steelers' search for an upgrade at wide receiver will continue into 2025 after the team failed to find a ...
AI Optics, a biotech startup backed by NYU Langone and raising in stealth, announced clearance this week from the Food and ...
Any NYT reader looking at the buzzy front page headline below would immediately think that Robert F. Kennedy Jr. is a madman. Can he really be an advocate for repealing the polio vaccine, a disease ...
The growing impacts of avian flu around the globe struck close to home this month with the outbreak at the Crescent Duck Farm in Aquebogue.
A chocolate recall was recently upgraded to warn consumers of a potential to “cause serious adverse health consequences of death.” ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
A New York state doctor was indicted by a Louisiana grand jury Friday for prescribing abortion medication via telehealth to a ...
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...